What is the Batch-CoA Gap?

The Batch-CoA Gap refers to discrepancies between a vape factory's Certificate of Analysis and the results Health Canada obtains when re-testing the same batch independently, often revealing inaccurate cannabinoid potency, contaminant levels, or undisclosed additives.

Why does Health Canada's lab pull show different results than the factory's CoA?

Factory testing may use different analytical methods, calibration standards, or sampling protocols than Health Canada's accredited labs, or in some cases, CoA data may not reflect the actual batch composition due to quality control gaps or intentional misrepresentation.

Can buyers identify a CoA reliability issue before Health Canada's inspection?

Request third-party re-testing from an independent accredited lab and cross-reference the factory's testing methodology and lab accreditation status; significant variances signal higher risk of regulatory failure.

What are the consequences if the Batch-CoA Gap is discovered during a Health Canada audit?

The batch can be seized, the manufacturer faces regulatory sanctions and potential license suspension, and any products already distributed may trigger recalls, exposing buyers to legal liability and reputational damage.

How can suppliers reduce CoA gaps in their sourcing agreements?

Require CoAs from Health Canada-recognized labs, mandate independent verification testing at buyer's expense, and include indemnification clauses that hold the supplier liable for discrepancies discovered post-shipment.

Manufacturing Intelligence Updated 2026-06-24 2 min read By the Agence Octo Sourcing Desk

Why Your Vape Factory's Certificate of Analysis Fails Health Canada's Lab Pull

The Batch-CoA Gap

A CoA tests what was tested. It does not test what shipped. Most vape importers buy the first and assume the second.

Sources

Official

BC E-Substances Reporting (BCER) portal — Notice of Intent to Sell E-Substances; product and manufacturing report requirements; six-week pre-sale filing window.
Health Canada — Vaping Compliance and Enforcement Report, April 2024–March 2025 (44 of 343 sampled products non-compliant with the 20 mg/mL nicotine cap).
Health Canada — nicotine concentration guidance for regulated parties.
SCC (Standards Council of Canada) — national accreditation body; ISO/IEC 17025 laboratory accreditation program for Canadian-market testing.
ILAC (International Laboratory Accreditation Cooperation) — mutual recognition arrangement; labs accredited by any ILAC MRA signatory body are cross-recognized across member economies.

Named third-party

(None cited in this iteration.)

Seller-reported

Cross-border vape importer reports: factories supply product-level specs by default; retroactive CoA paperwork after shipment; PO-release-condition workarounds.

Agence Octo methodology

Batch-CoA verification screen (five checks); product-line-vs-batch CoA distinction; inference that documentation gaps drive lab-pull failures.

Disclaimer: This article is sourcing intelligence, not legal, customs, or regulatory advice. BC BCER requirements and Health Canada enforcement policies are subject to change. Consult a licensed customs broker, attorney, or regulatory compliance specialist for compliance decisions related to vaping products.

*By the Agence Octo team.*

Why Your Vape Factory's Certificate of Analysis Fails Health Canada's Lab Pull

Sources

Keep reading